🇺🇸 Tempus AI, Inc.TEM

Company Update Form 8-K 23-10-2026 09:00:30 EDT

Subject: 8-K Items 8.01

Overview: Entered agreements with Bristol-Myers Squibb and Pathos AI for oncology and neurology data, totaling up to $192.5 million in aggregate cash payments.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest